• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pearls for opioid use in seriously ill patients.

作者信息

Kral Lee, Ku Jennifer, Kematick Benjamin S, Fudin Jeffrey

出版信息

J Pain Palliat Care Pharmacother. 2019 Mar-Jun;33(1-2):54-58. doi: 10.1080/15360288.2019.1650870. Epub 2019 Oct 8.

DOI:10.1080/15360288.2019.1650870
PMID:31592735
Abstract

Opioids are often the foundation of pain management in seriously ill patients. Unfortunately, even experienced providers carry with them information that they consider "fact", when this information is not based on scientific evidence, but on "myth". Several topics were elicited based on common beliefs and misconceptions in clinical practice. These were identified via a survey of pharmacist pain and palliative care providers. Pearls from these topics were chosen that were based on evidence and would have the greatest bearing on clinical practice. The pearls address topics such as not using opioids as first-line analgesics for all types of pain, opioid-induced hyperalgesia, opioid risk management in cancer patients, use of buprenorphine in hospice and palliative care settings and use of naloxone in seriously ill patients. The pearls are supported by clinical evidence extracted from several references. They are intended to make readers give thought to opioid therapy which is strictly evidence-based, and not historical or anecdote-based. Practical recommendations are provided to give readers a starting point to base clinical decisions going forward. Readers may discover that "facts" they once learned about opioid use in seriously ill patients are actually "myths" that are a figment of the past.

摘要

相似文献

1
Pearls for opioid use in seriously ill patients.
J Pain Palliat Care Pharmacother. 2019 Mar-Jun;33(1-2):54-58. doi: 10.1080/15360288.2019.1650870. Epub 2019 Oct 8.
2
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
3
Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients.针对丁丙诺啡维持治疗的阿片类药物依赖患者的医生-药剂师协作护理模式。
J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):187-92. doi: 10.1331/JAPhA.2015.14177.
4
Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus.静脉注射纳洛酮联合丁丙诺啡透皮贴剂治疗伴有顽固性胆汁淤积性瘙痒的癌症疼痛。
J Pain Symptom Manage. 2009 Oct;38(4):e5-8. doi: 10.1016/j.jpainsymman.2009.05.008. Epub 2009 Aug 21.
5
Establishment of a pharmacist-led service for patients at high risk for opioid overdose.为阿片类药物过量高风险患者建立由药剂师主导的服务。
Am J Health Syst Pharm. 2018 Mar 15;75(6):376-383. doi: 10.2146/ajhp170294.
6
[The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].[透皮7天丁丙诺啡贴剂——如果曲马多或替利定/纳洛酮疗效不足,这是一种有效且安全的治疗选择。一项非干预性研究的结果]
MMW Fortschr Med. 2010 Jul 1;152 Suppl 2:62-9.
7
Opioid risk assessment in palliative medicine.姑息医学中的阿片类药物风险评估。
Expert Opin Drug Saf. 2015 Jul;14(7):1023-33. doi: 10.1517/14740338.2015.1041915.
8
The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.经皮丁丙诺啡在癌痛治疗中的作用:专家小组共识。
Curr Med Res Opin. 2009 Jun;25(6):1517-28. doi: 10.1185/03007990902920731.
9
Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.开始接受阿片类物质使用障碍治疗的个体中丁丙诺啡/纳洛酮剂量与疼痛强度的关系
J Subst Abuse Treat. 2015 Jan;48(1):128-31. doi: 10.1016/j.jsat.2014.09.007. Epub 2014 Sep 26.
10
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.姑息治疗中的阿片类药物转换、根据临床需求选择阿片类药物以及阿片类药物的可及性。
Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.

引用本文的文献

1
A Regional Survey of Attitudes and Experiences in Determining When to Prescribe Intranasal Naloxone for Patients Seen in Palliative Care Clinics in the United States of America.对美国姑息治疗诊所中为患者开具鼻内纳洛酮的时机判定方面的态度与经验的区域调查。
Palliat Med Rep. 2024 Jul 19;5(1):286-292. doi: 10.1089/pmr.2024.0027. eCollection 2024.
2
Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care.临终关怀出院时阿片类药物处方量的下降趋势
J Pain Symptom Manage. 2021 Nov;62(5):1026-1033. doi: 10.1016/j.jpainsymman.2021.03.025. Epub 2021 Apr 10.